PureTech Health plc (PRTC.L)
GBp 164.0
(2.5%)
GBp 164.0
(2.5%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -146.19 Million USD | 26.09% |
| 2022 | -197.8 Million USD | -31.62% |
| 2021 | -150.28 Million USD | -25.73% |
| 2020 | -119.53 Million USD | 11.72% |
| 2019 | -135.39 Million USD | -30.17% |
| 2018 | -104.01 Million USD | 9.88% |
| 2017 | -115.42 Million USD | -56.12% |
| 2016 | -73.92 Million USD | -69.4% |
| 2015 | -43.64 Million USD | -150.17% |
| 2014 | -17.44 Million USD | -367.57% |
| 2013 | -3.73 Million USD | 60.25% |
| 2012 | -9.38 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -33.19 Million USD | 0.0% |
| 2024 Q1 | -33.19 Million USD | 5.19% |
| 2023 Q3 | -35.01 Million USD | 8.04% |
| 2023 Q4 | -35.01 Million USD | 0.0% |
| 2023 Q1 | -38.08 Million USD | 21.17% |
| 2023 Q2 | -38.08 Million USD | 0.0% |
| 2023 FY | -146.19 Million USD | 26.09% |
| 2022 Q1 | -50.59 Million USD | -23.1% |
| 2022 FY | -197.8 Million USD | -31.62% |
| 2022 Q4 | -48.3 Million USD | 0.0% |
| 2022 Q3 | -48.3 Million USD | 4.52% |
| 2022 Q2 | -50.59 Million USD | 0.0% |
| 2021 Q2 | -34.04 Million USD | 0.0% |
| 2021 FY | -150.28 Million USD | -25.73% |
| 2021 Q4 | -41.1 Million USD | 0.0% |
| 2021 Q3 | -41.1 Million USD | -20.74% |
| 2021 Q1 | -34.04 Million USD | -1.99% |
| 2020 Q1 | -26.39 Million USD | 18.9% |
| 2020 FY | -119.53 Million USD | 11.72% |
| 2020 Q2 | -26.39 Million USD | 0.0% |
| 2020 Q3 | -33.37 Million USD | -26.46% |
| 2020 Q4 | -33.37 Million USD | 0.0% |
| 2019 Q1 | -35.15 Million USD | -36.06% |
| 2019 Q3 | -32.54 Million USD | 7.44% |
| 2019 Q4 | -32.54 Million USD | 0.0% |
| 2019 Q2 | -35.15 Million USD | 0.0% |
| 2019 FY | -135.39 Million USD | -30.17% |
| 2018 Q4 | -25.83 Million USD | 0.0% |
| 2018 FY | -104.01 Million USD | 9.88% |
| 2018 Q3 | -25.83 Million USD | 1.26% |
| 2018 Q2 | -26.17 Million USD | 0.0% |
| 2018 Q1 | -26.17 Million USD | 10.09% |
| 2017 Q3 | -29.1 Million USD | -2.92% |
| 2017 FY | -115.42 Million USD | -56.12% |
| 2017 Q2 | -28.28 Million USD | 0.0% |
| 2017 Q1 | -28.28 Million USD | -43.69% |
| 2017 Q4 | -29.1 Million USD | 0.0% |
| 2016 Q4 | -19.68 Million USD | 0.0% |
| 2016 FY | -73.92 Million USD | -69.4% |
| 2016 Q2 | -17.28 Million USD | 0.0% |
| 2016 Q1 | -17.28 Million USD | -7.88% |
| 2016 Q3 | -19.68 Million USD | -13.9% |
| 2015 Q3 | -16.01 Million USD | -176.03% |
| 2015 Q2 | -5.8 Million USD | 0.0% |
| 2015 Q1 | -5.8 Million USD | 7.35% |
| 2015 FY | -43.64 Million USD | -150.17% |
| 2015 Q4 | -16.01 Million USD | 0.0% |
| 2014 Q2 | -2.45 Million USD | 0.0% |
| 2014 Q1 | -2.45 Million USD | 74.99% |
| 2014 FY | -17.44 Million USD | -367.57% |
| 2014 Q4 | -6.26 Million USD | 0.0% |
| 2014 Q3 | -6.26 Million USD | -154.72% |
| 2013 FY | -3.73 Million USD | 60.25% |
| 2013 Q1 | -915.5 Thousand USD | 0.0% |
| 2013 Q3 | -915.5 Thousand USD | 0.0% |
| 2013 Q2 | -915.5 Thousand USD | 0.0% |
| 2013 Q4 | -9.83 Million USD | -973.92% |
| 2012 Q3 | -2.47 Million USD | 0.0% |
| 2012 Q2 | -2.47 Million USD | 0.0% |
| 2012 Q1 | -2.47 Million USD | 0.0% |
| 2012 FY | -9.38 Million USD | 0.0% |
| 2012 Q4 | -915.5 Thousand USD | 63.05% |
| 2011 Q4 | -2.47 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|